Non-small cell lung cancer.
Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion.
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
David S
DS
Ettinger
Wallace
W
Akerley
Hossein
H
Borghaei
Andrew C
AC
Chang
Richard T
RT
Cheney
Lucian R
LR
Chirieac
Thomas A
TA
D'Amico
Todd L
TL
Demmy
Apar Kishor P
AK
Ganti
Ramaswamy
R
Govindan
Frederic W
FW
Grannis
Leora
L
Horn
Thierry M
TM
Jahan
Mohammad
M
Jahanzeb
Anne
A
Kessinger
Ritsuko
R
Komaki
Feng-Ming
FM
Kong
Mark G
MG
Kris
Lee M
LM
Krug
Inga T
IT
Lennes
Billy W
BW
Loo
Renato
R
Martins
Janis
J
O'Malley
Raymond U
RU
Osarogiagbon
Gregory A
GA
Otterson
Jyoti D
JD
Patel
Mary C
MC
Pinder-Schenck
Katherine M
KM
Pisters
Karen
K
Reckamp
Gregory J
GJ
Riely
Eric
E
Rohren
Scott J
SJ
Swanson
Douglas E
DE
Wood
Stephen C
SC
Yang
Miranda
M
Hughes
Kristina M
KM
Gregory
D000465:Algorithms; D014408:Biomarkers, Tumor / Q000032:analysis / Q000235:genetics; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D019411:Clinical Laboratory Techniques; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D008495:Medical Oncology / Q000331:legislation & jurisprudence / Q000379:methods*; D025202:Molecular Diagnostic Techniques; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011379:Prognosis; D012008:Recurrence
D014408:Biomarkers, Tumor